![Simona Skerjanec](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simona Skerjanec
Director/Board Member at
IMMUNIC, INC.
Net worth: - $ as of 2026-07-30
Profile
Simona Skerjanec is currently Director at BioVersys AG and Atrium Therapeutics, Inc. starting in 2026.
Ms. Skerjanec is also Independent Director at Immunic, Inc. since 2024.
Former roles include Independent Director at Avidity Biosciences, Inc. from 2024 to 2026, Senior Vice President at The Medicines Co., and Senior Vice President-Global Neuroscience at Roche Holding AG.
Education includes an MBA from Fairleigh Dickinson University and a graduate degree from the University of Ljubljana.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNIC, INC. -.--% | 2026-07-04 | 0 ( -.--% ) | - $ | 2026-07-30 |
-.--% | 2026-02-26 | 0 ( -.--% ) | - $ | 2026-07-30 |
Simona Skerjanec active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNIC, INC. | Director/Board Member | 2026-05-15 |
| BIOVERSYS AG | Director/Board Member | 2026-04-29 |
Former positions of Simona Skerjanec
| Companies | Position | End |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Director/Board Member | 2026-02-26 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
Training of Simona Skerjanec
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
54
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Fairleigh Dickinson University
 Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Ljubljana
 University of Ljubljana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioVersys AG
 BioVersys AG BiotechnologyHealth Technology Engages in research and development of small molecules on novel bacterial targets with application of AMR & antibiotic drugs | Health Technology |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Simona Skerjanec
